Delivery Order SPE2DB22D1106-SPE2DB25FEZN7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,453.56 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal...
- The Defense Logistics Agency awarded a delivery order valued at $21,884.70 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on July 17, 2025, with an ultimate completion date of July 18, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used to prevent pneumococcal disease in eligible populations, making this order part of...
- The Defense Logistics Agency awarded a delivery order valued at $5,170.98 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on June 16, 2025, with completion scheduled for June 17, 2025. This non-competed delivery order represents a firm fixed price transaction processed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $194,207.50 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed price contract. The award, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a direct procurement of this pneumococcal vaccine product to be performed at the vendor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $22,721.30 under a firm fixed-price contract. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization programs within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,220.22 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 11, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used to prevent pneumococcal disease across multiple age groups...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency awarded a delivery order valued at $8,274.97 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, supporting the federal government's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $16,390.61 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5ML syringes. This firm fixed-price, non-set-aside contract was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine critical to military and federal healthcare systems, supporting...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25,018 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-set-aside, competitively awarded contract reflects a firm fixed-price arrangement with an ultimate completion date of August 28, 2025. The delivery order was executed on August 27, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZN7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease, critical for military healthcare operations and veteran services. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to deliver vaccines, medications, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's award reflects its established capability to meet federal medical procurement requirements through open competition and positions it as a critical vendor supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 7/24/25 |